Product Description for MAP kinase p38 alpha / MAPK14
Rabbit anti Human, Mouse, Rat MAP kinase p38 alpha / MAPK14.
Presentation: Aff - Purified
Product is tested for Immunoprecipitation, Western blot / Immunoblot, Paraffin Sections.
Presentation: Aff - Purified
Product is tested for Immunoprecipitation, Western blot / Immunoblot, Paraffin Sections.
Properties for MAP kinase p38 alpha / MAPK14
| Product Category | Primary Antibodies |
|---|---|
| Quantity | 0.1 mg |
| Synonyms | CSBP, CSBP1, CSBP2, CSPB1, Cytokine suppressive anti-inflammatory drug-binding protein, MAX-interacting protein 2, MXI2, Mitogen-activated protein kinase 14, SAPK2A, p38 alpha |
| Presentation | Aff - Purified |
| Reactivity | Hu, Ms, Rt |
| Applications | IP, P, WB |
| Clonality | Polyclonal |
| Host | Rabbit |
| Shipping to | Worldwide |
| PDF datasheet | View Datasheet |
| Manufacturer | OriGene Technologies GmbH |
| Material safety datasheet | MSDS for Polyclonal Antibodies (de) |
Datasheet Extract
| Immunogen |
|
|---|---|
| Add. information | Blocking peptide (Cat. no. AP00039CP-N) is available separately. |
| Application | Western blotting (0.5-4.0 μg/ml). Immunoprecipitation (10-20 μg/ml). Immunohistochemistry (10-20 μg/ml). |
| Background | p38 MAP kinase is the mammalian homologue of the yeast HOG kinase and participates in a cascade controlling cell cellular responses to cytokines and stress. Like the SAPK/JNK pathway, p38 MAP kinase is activated by a variety of cellular stresses including inflammatory cytokines, UV light and growth factors, etc. Activated p38 MAP kinase has been shown to phosphorylate and activate MAPKAP kinase-2 and to phosphorylate the transcription factors ATF-2 and Max. |
| Concentration | 0.5 mg/ml |
| Storage | Store undiluted (in aliquots) at -20°C to -70 °C. Avoid repeated freezing and thawing. Shelf life: one year from despatch. |
| Format |
|
| Specificity |
|
| Gene ID | 1432 |
Accessory Products
Proteins and/or Positive Controls
Proteins for MAP kinase p38 alpha / MAPK14 (31 products)
| Catalog No. | Species | Pres. | Purity | Source | |||
|---|---|---|---|---|---|---|---|
| TP306605 |
MAP kinase p38 alpha / MAPK14 (transcript variant 2) |
||||||
|
Human |
> 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|||
| OriGene Technologies, Inc. | |||||||
| TP317425 |
MAP kinase p38 alpha / MAPK14 (transcript variant 1) |
||||||
|
Human |
> 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|||
| OriGene Technologies, Inc. | |||||||
| TP322774 |
MAP kinase p38 alpha / MAPK14 (transcript variant 4) |
||||||
|
Human |
> 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|||
| OriGene Technologies, Inc. | |||||||
| AR10187PU-L |
MAP kinase p38 alpha / MAPK14 (active kinase) |
||||||
|
Human | Purified | >95.0% as determined by SDS-PAGE | E. coli | |||
| OriGene Technologies GmbH | |||||||
| AR10187PU-N |
MAP kinase p38 alpha / MAPK14 (active kinase) |
||||||
|
Human | Purified | >95.0% as determined by SDS-PAGE | E. coli | |||
| OriGene Technologies GmbH | |||||||
| AR10187PU-S |
MAP kinase p38 alpha / MAPK14 (active kinase) |
||||||
|
Human | Purified | >95.0% as determined by SDS-PAGE | E. coli | |||
| OriGene Technologies GmbH | |||||||
| AR50125PU-N |
MAP kinase p38 alpha / MAPK14 (1-360, His-tag) |
||||||
|
Human | Purified | > 90 % by SDS - PAGE | E. coli |
0.5 mg /
€1,070.00
|
||
| OriGene Technologies GmbH | |||||||
| AR50125PU-S |
MAP kinase p38 alpha / MAPK14 (1-360, His-tag) |
||||||
|
Human | Purified | > 90 % by SDS - PAGE | E. coli |
0.1 mg /
€400.00
|
||
| OriGene Technologies GmbH | |||||||
| PA1234 |
MAP kinase p38 alpha / MAPK14 |
||||||
|
Human | Purified |
> 90 % Greater than 95.0% as determined by: (a)Analysis by RP-HPLC. (b)Analysis by SDS-PAGE. |
E. coli | |||
| OriGene Technologies GmbH | |||||||
| PA1234X |
MAP kinase p38 alpha / MAPK14 |
||||||
|
Human | Purified |
> 90 % Greater than 95.0% as determined by: (a)Analysis by RP-HPLC. (b)Analysis by SDS-PAGE. |
E. coli | |||
| OriGene Technologies GmbH | |||||||
| PA1234XC |
MAP kinase p38 alpha / MAPK14 |
||||||
|
Human | Purified |
> 90 % Greater than 95.0% as determined by: (a)Analysis by RP-HPLC. (b)Analysis by SDS-PAGE. |
E. coli | |||
| OriGene Technologies GmbH | |||||||
| H00001432-P01-10 |
MAP kinase p38 alpha / MAPK14 |
||||||
|
Human | 12.5% SDS-PAGE Stained with Coomassie Blue. | in vitro transl. | ||||
| Abnova Taiwan Corp. | |||||||
| H00001432-P01-25 |
MAP kinase p38 alpha / MAPK14 |
||||||
|
Human | 12.5% SDS-PAGE Stained with Coomassie Blue. | in vitro transl. | ||||
| Abnova Taiwan Corp. | |||||||
| H00001432-P02 |
MAP kinase p38 alpha / MAPK14 |
||||||
|
Human | Purified | |||||
| Abnova Taiwan Corp. | |||||||
| H00001432-P02-10 |
MAP kinase p38 alpha / MAPK14 |
||||||
|
Human | 12.5% SDS-PAGE Stained with Coomassie Blue. | in vitro transl. | ||||
| Abnova Taiwan Corp. | |||||||
| H00001432-P02-25 |
MAP kinase p38 alpha / MAPK14 |
||||||
|
Human | 12.5% SDS-PAGE Stained with Coomassie Blue. | in vitro transl. | ||||
| Abnova Taiwan Corp. | |||||||
| H00001432-Q01-10 |
MAP kinase p38 alpha / MAPK14 |
||||||
|
Human | 12.5% SDS-PAGE Stained with Coomassie Blue. | in vitro transl. | ||||
| Abnova Taiwan Corp. | |||||||
| H00001432-Q01-25 |
MAP kinase p38 alpha / MAPK14 |
||||||
|
Human | 12.5% SDS-PAGE Stained with Coomassie Blue. | in vitro transl. | ||||
| Abnova Taiwan Corp. | |||||||
| H00001432-Q02 |
MAP kinase p38 alpha / MAPK14 |
||||||
|
Human | Purified | |||||
| Abnova Taiwan Corp. | |||||||
| H00001432-Q02-10 |
MAP kinase p38 alpha / MAPK14 |
||||||
|
Human | 12.5% SDS-PAGE Stained with Coomassie Blue. | in vitro transl. | ||||
| Abnova Taiwan Corp. | |||||||
| H00001432-Q02-25 |
MAP kinase p38 alpha / MAPK14 |
||||||
|
Human | 12.5% SDS-PAGE Stained with Coomassie Blue. | in vitro transl. | ||||
| Abnova Taiwan Corp. | |||||||
| P1557 |
MAP kinase p38 alpha / MAPK14 |
||||||
|
Human | ||||||
| Abnova Taiwan Corp. | |||||||
| P1573 |
MAP kinase p38 alpha / MAPK14 |
||||||
|
Human | ||||||
| Abnova Taiwan Corp. | |||||||
| P2395 |
MAP kinase p38 alpha / MAPK14 |
||||||
|
Human | ||||||
| Abnova Taiwan Corp. | |||||||
| P2396 |
MAP kinase p38 alpha / MAPK14 |
||||||
|
Human | ||||||
| Abnova Taiwan Corp. | |||||||
| P2508 |
MAP kinase p38 alpha / MAPK14 |
||||||
|
Human | ||||||
| Abnova Taiwan Corp. | |||||||
| P2555 |
MAP kinase p38 alpha / MAPK14 |
||||||
|
Human | ||||||
| Abnova Taiwan Corp. | |||||||
| P4239 |
MAP kinase p38 alpha / MAPK14 |
||||||
|
Human | ||||||
| Abnova Taiwan Corp. | |||||||
| P4736 |
MAP kinase p38 alpha / MAPK14 |
||||||
|
Human | ||||||
| Abnova Taiwan Corp. | |||||||
| P5675 |
MAP kinase p38 alpha / MAPK14 |
||||||
|
Human | ||||||
| Abnova Taiwan Corp. | |||||||
| P5682 |
MAP kinase p38 alpha / MAPK14 |
||||||
|
Human | ||||||
| Abnova Taiwan Corp. | |||||||
Positive controls for MAP kinase p38 alpha / MAPK14 (5 products)
| Catalog No. | Species | Pres. | Purity | Source | |||
|---|---|---|---|---|---|---|---|
| H00001432-T01 |
MAPK14 293T Cell Transient Overexpression Lysate(Denatured) |
||||||
![]() |
|||||||
| Abnova Taiwan Corp. | |||||||
| LY408440 |
MAPK14 overexpression lysate |
||||||
![]() |
0.1 mg /
€295.00
|
||||||
| OriGene Technologies, Inc. | |||||||
| LY430080 |
MAPK14 overexpression lysate |
||||||
![]() |
0.1 mg /
€315.00
|
||||||
| OriGene Technologies, Inc. | |||||||
| NBL1-12873 |
MAP kinase p38 Lysate |
||||||
![]() |
|||||||
| Novus Biologicals Inc. | |||||||
| NBL1-12874 |
MAP kinase p38 Lysate |
||||||
![]() |
|||||||
| Novus Biologicals Inc. | |||||||
Recommended Secondary Antibodies for MAP kinase p38 alpha / MAPK14 (9 products)
| Catalog No. | Host | Clone/Iso. | Pres. | React. | Applications | ||
|---|---|---|---|---|---|---|---|
| R1364AP |
Rabbit IgG (H+L chain) antibody |
||||||
|
Goat | AP | Rb | E, WB | |||
| OriGene Technologies GmbH | |||||||
| R1364B |
Rabbit IgG (H+L chain) antibody |
||||||
|
Goat | Biotin | Rb | E, WB | |||
| OriGene Technologies GmbH | |||||||
| R1364F |
Rabbit IgG (H+L chain) antibody |
||||||
|
Goat | FITC | Rb | E, ICC/IF, WB | |||
| OriGene Technologies GmbH | |||||||
| R1364HRP |
Rabbit IgG (H+L chain) antibody |
||||||
|
Goat | HRP | Rb | E, P, WB | |||
| OriGene Technologies GmbH | |||||||
| R1364T |
Rabbit IgG (H+L chain) antibody |
||||||
|
Goat | TRITC | Rb | E, F, ICC/IF | |||
| OriGene Technologies GmbH | |||||||
| R1427R |
Rabbit IgG F(ab)2 Fragment (H+L chain) antibody |
||||||
|
Donkey | PE | Rb | F | |||
| OriGene Technologies GmbH | |||||||
| R1458C2 |
Rabbit IgG (H+L chain, adsorbed) antibody |
||||||
|
Goat | Cy2 | |||||
| OriGene Technologies GmbH | |||||||
| R1458C3 |
Rabbit IgG (H+L chain, adsorbed) antibody |
||||||
|
Goat | Cy3 | |||||
| OriGene Technologies GmbH | |||||||
| R1458C5 |
Rabbit IgG (H+L chain, adsorbed) antibody |
||||||
|
Goat | Cy5 | |||||
| OriGene Technologies GmbH | |||||||
![Western Blot: p38 Lysate [NBL1-12873] - Western Blot experiments.
Left-Control; Right -Over-expression Lysate for MAPK14](https://m1.acris-antibodies.com/catalog/product/cache/1/small_image/50x50/9df78eab33525d08d6e5fb8d27136e95/Novus/p38%20Lysate-Western%20Blot-NBL1-12873-img0001.jpg)
![Western Blot: p38 Lysate [NBL1-12874] - Western Blot experiments. Left-Control; Right -Over-expression Lysate for MAPK14.](https://m1.acris-antibodies.com/catalog/product/cache/1/small_image/50x50/9df78eab33525d08d6e5fb8d27136e95/Novus/p38%20Lysate-Western%20Blot-NBL1-12874-img0001.jpg)
